Syngene International Allots 7.29 Lakh Equity Shares Under Employee Incentive Plan

1 min read     Updated on 30 Apr 2026, 03:35 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Syngene International has completed the allotment of 7,29,727 equity shares to its Employee Welfare Trust under the Long Term Incentive Performance Share Unit Plan 2023, with Board approval received on April 29, 2026. The shares were issued at par value of Rs. 10 with no premium, increasing the total paid-up share capital to Rs. 403,66,91,470. The newly allotted shares rank pari-passu with existing equity shares and are listed on both NSE and BSE with no lock-in restrictions.

powered bylight_fuzz_icon
39031467

*this image is generated using AI for illustrative purposes only.

Syngene International has announced the allotment of 7,29,727 equity shares to the Syngene Employee Welfare Trust under the Syngene Long Term Incentive Performance Share Unit Plan 2023. The Board of Directors approved the allotment at its meeting held on April 29, 2026, in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Share Capital Impact

Consequent to the allotment, the company's paid-up share capital has increased from Rs. 402,93,94,200, comprising 40,29,39,420 equity shares of Rs. 10 each, to Rs. 403,66,91,470, comprising 40,36,69,147 equity shares of Rs. 10 each. The shares have been allotted at an exercise price of Rs. 10 per share with no premium.

Key Allotment Details

Particulars: Details
Number of shares issued: 7,29,727 equity shares
Date of issue: April 29, 2026
Par value per share: Rs. 10/-
Exercise price per share: Rs. 10/-
Premium per share: Nil
Distinctive numbers: 40,29,39,421 to 40,36,69,147
Total issued shares post-allotment: 40,36,69,147 shares
Total issued share capital post-allotment: Rs. 403,66,91,470

Regulatory Compliance and Listing

The equity shares allotted pursuant to the exercise of Performance Share Units rank pari-passu with the existing equity shares of the company. The shares are listed on both the National Stock Exchange of India Limited and BSE Limited. The company has confirmed that listing fees have been paid, and there is no lock-in applicable to the allotted shares.

Previous Approvals

The regulatory filing reveals that the company had previously received approvals for share allotments under the same plan. For 22,00,000 equity shares, BSE approval was received on July 26, 2023, and NSE approval on the same date. For an additional 45,29,000 equity shares, both exchanges provided approval on August 22, 2025.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
+8.21%+7.27%+12.52%-29.06%-25.64%-18.75%

How will the dilution from 7.29 lakh new shares impact Syngene's earnings per share and market valuation in the coming quarters?

What performance metrics must employees meet under the 2023 Long Term Incentive Plan to exercise their remaining share units?

Will Syngene expand its employee stock ownership programs further as the company scales its operations and workforce?

like15
dislike

Syngene International KMP Change: Siddharth Mittal Appointed MD & CEO from July 01, 2026

2 min read     Updated on 30 Apr 2026, 03:34 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Syngene International Limited has announced a leadership transition with Siddharth Mittal appointed as Managing Director & CEO effective July 01, 2026, replacing Peter Bains. The Board approved this KMP change on April 29, 2026 under Regulation 30 of SEBI Listing Regulations, with Mr. Mittal authorized to determine materiality of events and disclosures to stock exchanges.

powered bylight_fuzz_icon
39032610

*this image is generated using AI for illustrative purposes only.

Syngene International Limited has announced a significant change in its Key Managerial Personnel (KMP) structure, with the Board of Directors approving the appointment of Mr. Siddharth Mittal as the new Managing Director and Chief Executive Officer. The decision was made during a Board meeting held on April 29, 2026, pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Leadership Transition Details

Mr. Peter Bains will step down as the Managing Director & CEO effective from the close of business hours on June 30, 2026. Consequently, Mr. Siddharth Mittal will assume the role of Managing Director & CEO effective July 01, 2026. The Board has also approved amendments to the Policy on Determination of Materiality of Events and Information to be disclosed, authorizing Mr. Siddharth Mittal to determine materiality of events or information and make necessary disclosures to the Stock Exchange(s).

Parameter Details
Board Approval Date April 29, 2026
Outgoing MD & CEO Mr. Peter Bains
Incoming MD & CEO Mr. Siddharth Mittal
Transition Effective Date July 01, 2026

Key Managerial Personnel Structure

The company has outlined the current and revised KMP structure with complete contact details. Mr. Deepak Jain continues as Chief Financial Officer and Mr. Chethan Yogesh remains Company Secretary and Compliance Officer.

Current KMP Structure (As of April 29, 2026):

Position Name Email ID Contact No.
Managing Director & CEO Mr. Peter Bains Peterbains@syngeneintl.com 080-6891-3135
Chief Financial Officer Mr. Deepak Jain deepak.jain@syngeneintl.com 080-6775-9689
Company Secretary & Compliance Officer Mr. Chethan Yogesh Chethan.Yogesh@syngeneintl.com 080-6891-8781

New KMP Structure (Effective July 01, 2026):

Position Name Email ID Contact No.
Managing Director & CEO Mr. Siddharth Mittal siddharth.mittal1@syngeneintl.com 080-6891-3135
Chief Financial Officer Mr. Deepak Jain deepak.jain@syngeneintl.com 080-6775-9689
Company Secretary & Compliance Officer Mr. Chethan Yogesh Chethan.Yogesh@syngeneintl.com 080-6891-8781

Regulatory Compliance

The announcement has been made in compliance with Regulation 30(5) of SEBI Listing Regulations, 2015. The company has confirmed that this information will be made available on its official website at www.syngeneintl.com , ensuring transparency and adherence to regulatory requirements. The communication was formally signed by Chethan Yogesh, Company Secretary and Compliance Officer, on April 29, 2026.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
+8.21%+7.27%+12.52%-29.06%-25.64%-18.75%

What strategic changes might Syngene International implement under Mr. Siddharth Mittal's leadership compared to the previous management approach?

How could this leadership transition impact Syngene's competitive position in the contract research and manufacturing services sector?

Will the new CEO's appointment lead to any shifts in Syngene's geographic expansion plans or client acquisition strategy?

like15
dislike

More News on Syngene International

1 Year Returns:-25.64%